2026 · Nature Aging
A microprotein atlas of the human frontal cortex in Alzheimer’s disease
Verdict
UNSCIENTIFIC
Neither the paradigm nor the study inside it passes. The verdict is unscientific.
1·Study methodology · inside the paradigm
UNSCIENTIFIC
Does not follow the scientific method within Genomics / DNA Model.
2·Paradigm · Genomics / DNA Model
UNSCIENTIFIC
Fails the tests. This decides the verdict.
How the verdict is decided
The verdict grades the whole picture: the paradigm this study assumes, and how the study was carried out inside it. A study can follow the scientific method rigorously and still be unscientific, because rigor inside a paradigm only shows the conclusion was reached carefully. It cannot verify the premise the paradigm rests on. So the paradigm decides the verdict. The study’s own score is kept because it shows how the conclusion was built.
1·Study methodology
Did this study test its claim with methods that are independent, falsifiable, and non-circular?
UNSCIENTIFIC
This paper claims that 1,067 tiny proteins exist in the human brain and that some change in Alzheimer's disease, identified by matching mass spectrometry signals against computer-generated predictions built from assembled sequences. All three tests fail.
Independently Verifiable
Fail
The mass spectrometer produced peaks on a graph and the model told them those peaks were tiny proteins, but a stranger looking at the same graph sees peaks, not microproteins.
Falsifiable
Fail
The study used computer-generated predictions to guarantee that matches would be found, so no result in this design could have shown that the claimed microproteins do not exist.
Non-Circular
Fail
They assembled sequences using the DNA model, predicted tiny proteins from those assemblies, generated fake mass data for the predictions, and then matched real signals against the fake data to confirm the predictions.
Why
They took brain tissue from over 600 dead people and extracted chemical fractions from it. Sequencing machines produced fluorescent signals, and software interpreted those signals as RNA fragments using the DNA model. A computer predicted tiny proteins from the assembled sequences. Another computer generated fake mass spectrometry data for those predictions. Real signals from the brain fractions were matched against the fake data. They called the matches newly discovered microproteins. At no point did anyone see a microprotein. They saw signals on a screen and the model told them what the signals meant. The study claims 1,067 of these tiny proteins exist in the brain, with some changing in Alzheimer's patients. But the detection depended entirely on predictions built from assembled sequences. The tool was built to find what the model already named. No result in this design could have contradicted the microprotein claim, because the predictions guaranteed matches would be found.
2·Paradigm · Genomics / DNA Model
Does the framework this study assumes pass the three tests?
UNSCIENTIFIC
Independently Verifiable
Fail
The claimed microproteins only exist as the model's interpretation of mass spectrometry peaks matched against computer-generated predictions, so someone who rejects the DNA model sees nothing but signals.
Falsifiable
Fail
When a predicted microprotein failed to appear in the mass spec data, the study could call it low abundance or technical limitation, so the microprotein concept never faced a real test.
Non-Circular
Fail
Sequences were computationally assembled using the DNA model, predictions were generated from those assemblies, and detection was matched against those same predictions.
Why
The DNA model claims that sequences extracted from tissue represent a hereditary code that produces proteins. This paper takes that claim and extends it to tiny proteins nobody had seen before. The model assembles signals into sequences, predicts proteins from those sequences, generates fake mass data for the predictions, matches real signals against the fake data, and calls the matches discovery. Every step depends on the model being correct first. If the model is wrong about what the sequences mean, the entire atlas is an artifact of circular reasoning. The Alzheimer's field has spent decades failing to explain neurodegeneration through this framework. Adding 1,067 more model-dependent entities does not change that. The model treats a protein's absence or presence as the cause of disease, when the real question is what damaged the brain tissue in the first place. Suppressing or restoring a single microprotein would be called treatment, while the terrain damage that caused the brain to deteriorate goes unaddressed.
From the paper
we present a brain MP atlas that integrates transcriptomics, mass spectrometry and deep-learning-predicted spectra across more than 600 postmortem frontal cortex samples with and without Alzheimer's disease (AD).
We identified 1,067 MPs absent from reviewed UniProtKB entries with high-confidence spectral support.
Source
A microprotein atlas of the human frontal cortex in Alzheimer’s disease
Miller, Brendan; Vieira de Souza, Eduardo; Lau, Calvin; Vaughan, Joan M.; Pai, Victor J.; Giraldez, Servando; Rocha, Andréa; Diedrich, Jolene K.; O’Shea, Clodagh C.; Bennett, David A.; Saghatelian, Alan
2026 · Nature Aging
Scored from abstract only · Rubric 1.0